Profiling the subjective effects of Δ 9 ‐tetrahydrocannabinol using visual analogue scales
Abstract The subjective effects of cannabis and its main psychoactive component Δ 9 ‐tetrahydrocannabinol (THC) have played an important part in determining the therapeutic potential of cannabinoid agonists and antagonists. The effects mainly consist of feeling high, changes in perception, feelings...
Saved in:
Published in | International journal of methods in psychiatric research Vol. 23; no. 2; pp. 245 - 256 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
01.06.2014
|
Online Access | Get full text |
Cover
Loading…
Abstract | Abstract
The subjective effects of cannabis and its main psychoactive component Δ
9
‐tetrahydrocannabinol (THC) have played an important part in determining the therapeutic potential of cannabinoid agonists and antagonists. The effects mainly consist of feeling high, changes in perception, feelings of relaxation and occasionally dysphoric reactions. These effects are captured by two of the most frequently used visual analogue scales (VASs) in clinical (pharmacologic) research to measure subjective effects: VAS Bond and Lader (alertness, calmness and mood) and VAS Bowdle (psychedelic effects). In this analysis, the effects of THC on these VASs were compared within a total of 217 subjects who participated in 10 different studies. Not surprisingly, the item feeling high was found to be the best predictor for the effect of THC. Three separate clusters that describe the spectrum of subjective effects of THC were identified using different statistical methods, consisting of VAS “time”, “thoughts” and “high” (“perception”), VAS “drowsy”, “muzzy”, “mentally slow” and “dreamy” (“relaxation”) and VAS “voices”, “meaning” and “suspicious” (“dysphoria”). These results provide experimental evidence that THC can evoke different classes of effects. These distinct subjective clusters could represent effects on various systems in the brain, which can be used to further differentiate the involvement of endocannabinoid systems in health and disease. Copyright © 2014 John Wiley & Sons, Ltd. |
---|---|
AbstractList | Abstract
The subjective effects of cannabis and its main psychoactive component Δ
9
‐tetrahydrocannabinol (THC) have played an important part in determining the therapeutic potential of cannabinoid agonists and antagonists. The effects mainly consist of feeling high, changes in perception, feelings of relaxation and occasionally dysphoric reactions. These effects are captured by two of the most frequently used visual analogue scales (VASs) in clinical (pharmacologic) research to measure subjective effects: VAS Bond and Lader (alertness, calmness and mood) and VAS Bowdle (psychedelic effects). In this analysis, the effects of THC on these VASs were compared within a total of 217 subjects who participated in 10 different studies. Not surprisingly, the item feeling high was found to be the best predictor for the effect of THC. Three separate clusters that describe the spectrum of subjective effects of THC were identified using different statistical methods, consisting of VAS “time”, “thoughts” and “high” (“perception”), VAS “drowsy”, “muzzy”, “mentally slow” and “dreamy” (“relaxation”) and VAS “voices”, “meaning” and “suspicious” (“dysphoria”). These results provide experimental evidence that THC can evoke different classes of effects. These distinct subjective clusters could represent effects on various systems in the brain, which can be used to further differentiate the involvement of endocannabinoid systems in health and disease. Copyright © 2014 John Wiley & Sons, Ltd. |
Author | Freijer, Jan De Winter, Willem Roozen, Frits Van Gerven, Joop Kleinloog, Daniël |
Author_xml | – sequence: 1 givenname: Daniël surname: Kleinloog fullname: Kleinloog, Daniël organization: Centre for Human Drug Research Leiden The Netherlands – sequence: 2 givenname: Frits surname: Roozen fullname: Roozen, Frits organization: Centre for Human Drug Research Leiden The Netherlands – sequence: 3 givenname: Willem surname: De Winter fullname: De Winter, Willem organization: Centre for Human Drug Research Leiden The Netherlands – sequence: 4 givenname: Jan surname: Freijer fullname: Freijer, Jan organization: Centre for Human Drug Research Leiden The Netherlands – sequence: 5 givenname: Joop surname: Van Gerven fullname: Van Gerven, Joop organization: Centre for Human Drug Research Leiden The Netherlands |
BookMark | eNotkMtKAzEYhYMo2FbBR8jSzdTck1lK8QYFXXQrwz-ZpJ0yTUoyU-jOR3Dhc_kQPolTdHXO5nwcvik6DzE4hG4omVNC2N1un-ZUMHGGJlRKXRAl9fnYiSgLU3J6iaY5bwmhhjE1Qe9vKfq2a8Ma9xuH81Bvne3bg8PO-7FlHD3-_sIl_vn47F2fYHNsUrQQAtRtiB0e8ml8aPMAHYYAXVwPI8hC5_IVuvDQZXf9nzO0enxYLZ6L5evTy-J-WVjNRMG18cZZx0ETJpURtZWcGwpcCqvqplaN0Uo2rCTcUc_NeN36xivhAbRVfIZu_7A2xZyT89U-tTtIx4qS6mSlGq1UJyv8FwXoWec |
CitedBy_id | crossref_primary_10_1097_YIC_0000000000000544 crossref_primary_10_1097_MD_0000000000025363 crossref_primary_10_1097_YIC_0000000000000498 crossref_primary_10_1007_s00702_016_1630_6 crossref_primary_10_3389_fpsyt_2020_576877 crossref_primary_10_1038_s41398_022_02112_8 crossref_primary_10_1016_j_euroneuro_2019_03_010 crossref_primary_10_1016_j_drugalcdep_2020_108225 crossref_primary_10_2196_24433 crossref_primary_10_1016_j_drugalcdep_2023_110925 crossref_primary_10_1177_0269881115570082 crossref_primary_10_1038_s44220_024_00261_x crossref_primary_10_1097_JCP_0000000000001457 crossref_primary_10_1016_j_drugpo_2024_104457 crossref_primary_10_1089_can_2017_0018 crossref_primary_10_1111_add_14959 crossref_primary_10_1016_j_psychres_2014_10_010 crossref_primary_10_1089_brain_2014_0314 crossref_primary_10_3389_fnins_2023_1163600 |
Cites_doi | 10.1111/j.1365‐2125.2011.03970.x 10.1097/JCP.0b013e318204825b 10.1017/S0033291712001924 10.1111/bcp.12071 10.1192/bjp.178.2.101 10.1016/S0163‐7258(02)00257‐7 10.2307/2346830 10.1111/bcp.12141 10.1111/j.1365‐2125.2008.03329.x 10.1016/S0140‐6736(05)66374‐X 10.1038/npp.2008.138 10.1038/sj.npp.1395214 10.1017/S1461145711000526 10.1201/9781420011234 10.1016/j.neuroimage.2012.07.051 10.2165/11585260-000000000-00000 10.1111/j.2044‐8341.1974.tb02285.x 10.1038/sj.npp.1300496 10.1177/0269881108089870 10.2165/11539000-000000000-00000 10.1002/ptr.3375 10.1192/bjp.bp.109.072249 10.1016/0028‐3908(71)90039‐6 10.1001/archgenpsychiatry.2010.152 10.1177/0269881112446534 10.1111/j.1365‐2125.2011.04164.x 10.1038/npp.2009.184 10.1136/bmj.38267.664086.63 10.1145/331499.331504 |
ContentType | Journal Article |
DBID | AAYXX CITATION |
DOI | 10.1002/mpr.1424 |
DatabaseName | CrossRef |
DatabaseTitle | CrossRef |
DatabaseTitleList | CrossRef |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1557-0657 |
EndPage | 256 |
ExternalDocumentID | 10_1002_mpr_1424 |
GroupedDBID | --- .3N .GA .Y3 05W 0R~ 10A 1L6 1OC 24P 29J 31~ 33P 36B 3SF 3WU 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8FI 8FJ 8UM 930 A01 A03 AAESR AAEVG AAHHS AAONW AAYXX AAZKR ABCQN ABCUV ABDBF ABEML ABIJN ABIVO ABLJU ABUWG ACBWZ ACCFJ ACGFS ACHQT ACMXC ACPOU ACSCC ACXQS ADBBV ADEOM ADIZJ ADMGS ADPDF ADXAS ADZOD AEEZP AEIMD AENEX AEQDE AEUQT AFBPY AFGKR AFKRA AFPWT AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR ASPBG ATUGU AVWKF AZBYB AZFZN AZQEC AZVAB BAFTC BDRZF BENPR BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CCPQU CITATION CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DU5 DWQXO EAD EAP EAS EBC EBD EBS EJD EMB EMK EMOBN EPL EPS ESX F00 F01 F04 F5P FEDTE FUBAC FYUFA G-S G.N GNP GNUQQ GODZA GROUPED_DOAJ H.X HF~ HVGLF HZ~ IAO IHR ITC IX1 J0M JPC LAW LC2 LC3 LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M2M MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 NF~ O66 O9- OIG OK1 OVD OVEED P2P P2W P2X P2Z P4B P4D PIMPY PQQKQ PSYQQ Q.N Q11 QB0 QRW R.K ROL RPM RWI RX1 SUPJJ SV3 TEORI TUS UB1 UKHRP W8V W99 WBKPD WHWMO WIH WIJ WIK WIN WOHZO WQJ WRC WVDHM WXI XG1 XV2 ZZTAW ~IA ~WT |
ID | FETCH-LOGICAL-c724-378f8ece3a7025684bc53381a354c6bdb6d8765d2903e1f38822cfdf64faa7c63 |
ISSN | 1049-8931 |
IngestDate | Thu Sep 26 16:12:09 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c724-378f8ece3a7025684bc53381a354c6bdb6d8765d2903e1f38822cfdf64faa7c63 |
PageCount | 12 |
ParticipantIDs | crossref_primary_10_1002_mpr_1424 |
PublicationCentury | 2000 |
PublicationDate | 2014-06-00 |
PublicationDateYYYYMMDD | 2014-06-01 |
PublicationDate_xml | – month: 06 year: 2014 text: 2014-06-00 |
PublicationDecade | 2010 |
PublicationTitle | International journal of methods in psychiatric research |
PublicationYear | 2014 |
References | e_1_2_7_6_1 e_1_2_7_5_1 e_1_2_7_4_1 e_1_2_7_3_1 e_1_2_7_8_1 e_1_2_7_7_1 e_1_2_7_18_1 e_1_2_7_17_1 Compton D.R. (e_1_2_7_9_1) 1996; 277 e_1_2_7_16_1 e_1_2_7_2_1 e_1_2_7_15_1 e_1_2_7_14_1 e_1_2_7_13_1 e_1_2_7_12_1 e_1_2_7_11_1 e_1_2_7_10_1 e_1_2_7_26_1 e_1_2_7_27_1 e_1_2_7_28_1 e_1_2_7_29_1 Jolliffe I.T. (e_1_2_7_19_1) 2002 e_1_2_7_30_1 e_1_2_7_25_1 e_1_2_7_31_1 e_1_2_7_24_1 e_1_2_7_32_1 e_1_2_7_23_1 e_1_2_7_33_1 e_1_2_7_22_1 e_1_2_7_34_1 e_1_2_7_21_1 e_1_2_7_35_1 e_1_2_7_20_1 |
References_xml | – ident: e_1_2_7_28_1 doi: 10.1111/j.1365‐2125.2011.03970.x – ident: e_1_2_7_21_1 doi: 10.1097/JCP.0b013e318204825b – ident: e_1_2_7_3_1 doi: 10.1017/S0033291712001924 – ident: e_1_2_7_25_1 doi: 10.1111/bcp.12071 – ident: e_1_2_7_2_1 doi: 10.1192/bjp.178.2.101 – ident: e_1_2_7_4_1 doi: 10.1016/S0163‐7258(02)00257‐7 – volume-title: Principal Component Analysis year: 2002 ident: e_1_2_7_19_1 contributor: fullname: Jolliffe I.T. – ident: e_1_2_7_14_1 doi: 10.2307/2346830 – ident: e_1_2_7_26_1 doi: 10.1111/bcp.12141 – ident: e_1_2_7_34_1 doi: 10.1111/j.1365‐2125.2008.03329.x – ident: e_1_2_7_30_1 doi: 10.1016/S0140‐6736(05)66374‐X – ident: e_1_2_7_7_1 doi: 10.1038/npp.2008.138 – ident: e_1_2_7_8_1 doi: 10.1038/sj.npp.1395214 – ident: e_1_2_7_15_1 doi: 10.1017/S1461145711000526 – volume: 277 start-page: 586 issue: 2 year: 1996 ident: e_1_2_7_9_1 article-title: In vivo characterization of a specific cannabinoid receptor antagonist (SR141716A): inhibition of delta 9‐tetrahydrocannabinol‐induced responses and apparent agonist activity publication-title: Journal of Pharmacology and Experimental Therapeutics contributor: fullname: Compton D.R. – ident: e_1_2_7_12_1 doi: 10.1016/S0140‐6736(05)66374‐X – ident: e_1_2_7_13_1 doi: 10.1201/9781420011234 – ident: e_1_2_7_24_1 doi: 10.1016/j.neuroimage.2012.07.051 – ident: e_1_2_7_20_1 doi: 10.2165/11585260-000000000-00000 – ident: e_1_2_7_6_1 doi: 10.1111/j.2044‐8341.1974.tb02285.x – ident: e_1_2_7_10_1 doi: 10.1038/sj.npp.1300496 – ident: e_1_2_7_35_1 doi: 10.1177/0269881108089870 – ident: e_1_2_7_32_1 doi: 10.2165/11539000-000000000-00000 – ident: e_1_2_7_11_1 doi: 10.1002/ptr.3375 – ident: e_1_2_7_17_1 doi: 10.1192/bjp.bp.109.072249 – ident: e_1_2_7_29_1 doi: 10.1016/0028‐3908(71)90039‐6 – ident: e_1_2_7_27_1 doi: 10.1017/S1461145711000526 – ident: e_1_2_7_31_1 doi: 10.1001/archgenpsychiatry.2010.152 – ident: e_1_2_7_22_1 doi: 10.1177/0269881112446534 – ident: e_1_2_7_23_1 doi: 10.1111/j.1365‐2125.2011.04164.x – ident: e_1_2_7_5_1 doi: 10.1038/npp.2009.184 – ident: e_1_2_7_16_1 doi: 10.1136/bmj.38267.664086.63 – ident: e_1_2_7_18_1 doi: 10.1145/331499.331504 – ident: e_1_2_7_33_1 doi: 10.1177/0269881108089870 |
SSID | ssj0018226 |
Score | 2.0584507 |
Snippet | Abstract
The subjective effects of cannabis and its main psychoactive component Δ
9
‐tetrahydrocannabinol (THC) have played an important part in determining... |
SourceID | crossref |
SourceType | Aggregation Database |
StartPage | 245 |
Title | Profiling the subjective effects of Δ 9 ‐tetrahydrocannabinol using visual analogue scales |
Volume | 23 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NattAEF7cGEIvoW1S2qQtW2hORqm9Wq2lY5zYhIBLCS7kUszualVsXCnEUiA55RF66IP0SfoQfZKMNLuSSHNIexFmbcl45_P87TczhHwIecgHJhCeHEKsysEge1KHwotl0BcsAZfELwuFp5_EyRd-eh6cdzq_WqylIlcH-ubBupL_kSqsgVzLKtl_kGz9UFiA1yBfuIKE4fooGX-uBm67gqd1oZaovtosjf2j8X7EexD7O1pDbnLQMNcxmC6ZphJC42zVK6qcwdViXVTNAzCl01uDBC3JcNlQ3psMYqvvBI6iRla6Y1BX7aFb6bJSsa_MIl1l2TdX316d1I9qnsdZlt0Y61Iv8mbqvQH9ldohImWOyGacq7oVs1jiG6cW6jaLMeAN28oqXohUPPCdcMlYZRyU1DxsYO20NVYnW1SyturFtpTWijNsV_6XgcCGs98vLg_KEr_GCLqD_3u2sWYsYndnNoc75-WdT0iXgWoDndo9HB2PJvXJFThcAjtg4O9xDY_77KP71pYL1PJlZs_Ilg1C6CEi6jnpmPQF2ZxamsU2-VoDiwKwaAMsaoFFs4T-_kkj-uf2x0NwohWcKMKJOjhRhNMOmU3Gs6MTz87h8PSQcTBBYRIabXz4O8O2hlxpiBHCgfQDroWKlYjBpAYxi_q-GSQ-xGxMJ3EieCLlUAv_JdlIs9S8IhQe4ceRDCLw23kcMhUYlWhech-k6Svzmrx3OzO_wG4r8_s7v_uIz-yRpw3I3pCN_LIwb8F5zNU7K6874LN1kQ |
link.rule.ids | 315,783,787,27936,27937 |
linkProvider | EBSCOhost |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Profiling+the+subjective+effects+of+%CE%94+9+%E2%80%90tetrahydrocannabinol+using+visual+analogue+scales&rft.jtitle=International+journal+of+methods+in+psychiatric+research&rft.au=Kleinloog%2C+Dani%C3%ABl&rft.au=Roozen%2C+Frits&rft.au=De+Winter%2C+Willem&rft.au=Freijer%2C+Jan&rft.date=2014-06-01&rft.issn=1049-8931&rft.eissn=1557-0657&rft.volume=23&rft.issue=2&rft.spage=245&rft.epage=256&rft_id=info:doi/10.1002%2Fmpr.1424&rft.externalDBID=n%2Fa&rft.externalDocID=10_1002_mpr_1424 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1049-8931&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1049-8931&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1049-8931&client=summon |